SCHEMBL18204

SCHEMBL18204

CCC[C@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc([C@](C)(O)C(F)(F)F)cc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.74
GCKR Q14397 8/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18320 1.00 GCK (0.74) GCKGCKR
SCHEMBL12078504 0.91 GCK (0.76) GCKGCKR
SCHEMBL16424 0.91 GCK (0.76) GCKGCKR
SCHEMBL17603 0.91 GCK (0.76) GCKGCKR
SCHEMBL16196 0.91 GCK (0.76) GCKGCKR
SCHEMBL17161 0.91 GCK (0.76) GCKGCKR
SCHEMBL16961 0.91 GCK (0.76) GCKGCKR
SCHEMBL16268 0.91 GCK (0.76) GCKGCKR
SCHEMBL12078490 0.91 GCK (0.76) GCKGCKR
SCHEMBL15200872 0.89 GCKR (0.75) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed